AXOGEN INC. - COMMON STOCK

NetDania - New 12 months Low: AXOGEN INC. - COMMON STOCK

08 8 2023 09:56:21 提供 NetDania Notify

Axogen, Inc. Reports 2023 Second Quarter Financial Results

07 8 2023 16:01:10 提供 Nasdaq GlobeNewswire

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

27 7 2023 07:00:01 提供 Nasdaq GlobeNewswire

Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023

26 7 2023 07:00:01 提供 Nasdaq GlobeNewswire

Axogen to Participate at Jefferies Healthcare Conference

24 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen to Participate at JMP Securities Life Sciences Conference

12 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 First Quarter Financial Results

09 5 2023 07:00:03 提供 Nasdaq GlobeNewswire

Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023

18 4 2023 16:05:00 提供 Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

14 3 2023 07:00:01 提供 Nasdaq GlobeNewswire

Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel

06 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023

02 3 2023 16:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

13 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

09 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

05 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

04 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

19 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Third Quarter Financial Results

08 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

03 11 2022 16:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.

31 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022

20 10 2022 07:00:01 提供 Nasdaq GlobeNewswire